The Latest in Hematology News

Using engineered T cells reduced acute, chronic GVHD

February 23, 2021

Transplant-related mortality higher with CD34 selection

February 22, 2021

Large study finds trans men on testosterone at risk for blood clots

February 22, 2021

Thrombosis

Novel ddPCR assay precisely measures CAR T-cells after infusion

February 22, 2021

Steroid complications in GVHD common, boost costs of care

February 19, 2021

Ivabradine knocks down heart rate, symptoms in POTS

February 19, 2021

COVID-19 Updates

Routine COVID-19 screening unnecessary for cancer outpatients

February 19, 2021

COVID-19 Updates

Roots of physician burnout: It’s the work load

February 19, 2021

Business of Medicine

CDC chief lays out attack plan for COVID variants

February 19, 2021

COVID-19 Updates

CAR T-cell products shine in real-world setting, reveal new insights

February 18, 2021

Alien cells may explain COVID-19 brain fog

February 18, 2021

COVID-19 Updates

Seen or viewed: A black hematologist’s perspective

February 18, 2021

Diversity in Medicine

Chronic GVHD therapies offer hope for treating refractory disease

February 17, 2021

Prognostic gene signature identifies high- vs. low-risk DLBCL patients

February 17, 2021

Don’t fear patients reading their clinical notes: Opinion

February 17, 2021

Business of Medicine